الحملات
View Allالوثائق
View Allالمركز الإعلامي
View All
SFDA Strengthens Its Global Leadership in Drug Regulation with Launch of NADR Program for Rare Disease Drug Development
Reinforcing its position as a leading global regulatory authority, the Saudi Food and Drug Authority (SFDA) has launched the New Accelerator Program...
SFDA Becomes First Regulatory Authority Globally to Approve the Registration of 'ZENBEXUS' for the T
The Saudi Food and Drug Authority (SFDA) has approved the registration of ZENBEXUS (iberdomide) for the treatment of adult patients with relapsed or...
SFDA Approves Registration of "Foundayo" for Weight Management
The Saudi Food and Drug Authority (SFDA) has approved the registration of Foundayo (orforglipron) to help reduce excess body weight and maintain long...
SFDA Suspends Registration of Drug Tavneos (avacopan)
The Saudi Food and Drug Authority (SFDA) has announced the suspension of the registration for the drug (Avacopan), commercially known as Tavneos. This...
SFDA Grants Orphan Drug Designation to Gritgen Therapeutics for PKU Treatment
The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gritgen Therapeutics Co., Ltd. for its “GS1168 Injection” intended for...
SFDA Approves Registration of “Iqirvo” for the Treatment of Primary Biliary Cholangitis
The Saudi Food and Drug Authority (SFDA) has approved the registration of Iqirvo (Elafibranor) for the treatment of adults with primary biliary...
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.